TP53 and intrahepatic cholangiocarcinoma: We then used an oncogenic KrasG12D as a donor and delivered this to wildtype B6 or FVB mice along with a guide RNA targeting p53. As expected, CRISPR-SONIC delivery of mutant Kras cooperated with sgp53 to induce ICC in vivo (Fig. 4).